J.D. Eneman

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

Theresa Casey, Jeffrey P. Bond, Scott Tighe et al. · Breast Cancer Research and Treatment · 2008 · 219 citations

Stromal Cells, Breast Oncology, Major Role +9

Characterization of cadmium-induced apoptosis in rat lung epithelial cells: evidence for the participation of oxidant stress

Beth A. Hart, C.H. Lee, G. S. Shukla et al. · Toxicology · 1999 · 198 citations

Inflammation, Lung Inflammation, Respiratory Toxicology +14

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study)

Jeffrey I. Zwicker, Howard A. Liebman, Kenneth A. Bauer et al. · British Journal of Haematology · 2012 · 137 citations · Full text

Cancer Management, Pharmacotherapy, Cancer Patients +21

Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study

Theresa Casey, J.D. Eneman, Abigail Crocker et al. · Breast Cancer Research and Treatment · 2007 · 124 citations

Tumor Biology, Medicine, Cancer Cell Biology +12